Close
4

Quotient Sciences Quotient Sciences

X

Company profile for Sorrento Therapeutics

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
Sorrento Therapeutics, Inc (Nasdaq: SRNE) is a clinical stage, antibody-centric, biopharmaceutical company developing new therapies to turn malignant cancers into manageable and possibly curable diseases. Cancers are genetically diverse, highly adaptive, constantly mutating and virtually invisible to the immune system. Therefore, we believe any single target therapy is destined to fail. Our approach to cancer therapy is based ...
Sorrento Therapeutics, Inc (Nasdaq: SRNE) is a clinical stage, antibody-centric, biopharmaceutical company developing new therapies to turn malignant cancers into manageable and possibly curable diseases. Cancers are genetically diverse, highly adaptive, constantly mutating and virtually invisible to the immune system. Therefore, we believe any single target therapy is destined to fail. Our approach to cancer therapy is based on the belief that patients will require a multimodal, multipronged approach – targeting a single or diverse set of cellular targets.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Sorrento Therapeutics
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
4955 Directors Place San Diego, CA 92121
Telephone
Telephone
(858) 203-4100
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY